0.9617
-0.0083 (-0.86%)
-0.0083 (-0.86%)
Upgrade to Real-Time
Regular Market
Low
0.6651
High
3.65
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Timber Pharmaceuticals Inc | TMBR | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.0083 | -0.86% | 0.9617 | 12:41:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.982 | 0.9502 | 0.982 | 0.97 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 444 | 228,149 | $ 0.9631669 | $ 219,746 | - | 0.6651 - 3.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:47:34 | 11 | $ 0.96 | USD |
Period:
Draw Mode:
Timber Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 35.43M | 36.84M | 31.30M | $ - | $ - | -1.04 | -1.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -826.46k | - |
Timber Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TMBR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.02 | 1.06 | 0.9151 | 0.9766504 | 683,315 | -0.0583 | -5.72% |
| 1 Month | 1.27 | 1.28 | 0.9151 | 1.10 | 814,859 | -0.3083 | -24.28% |
| 3 Months | 1.60 | 1.61 | 0.9151 | 1.19 | 1,264,451 | -0.6383 | -39.89% |
| 6 Months | 1.28 | 3.65 | 0.9151 | 2.27 | 5,158,516 | -0.3183 | -24.87% |
| 1 Year | 2.02 | 3.65 | 0.6651 | 1.92 | 3,550,740 | -1.06 | -52.39% |
| 3 Years | 4.11 | 4.17 | 0.6651 | 1.95 | 3,179,051 | -3.15 | -76.6% |
| 5 Years | 4.11 | 4.17 | 0.6651 | 1.95 | 3,179,051 | -3.15 | -76.6% |
Timber Pharmaceuticals Description
| Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and scleroderma. The company's development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist). |
